Acotec Scientific Wins PRC Approval for Coronary Over-the-Wire Balloon Catheter

Reuters
11/18
Acotec Scientific Wins PRC Approval for Coronary Over-the-Wire Balloon Catheter

Acotec Scientific Holdings Limited has announced that it has received registration approval from the PRC National Medical Products Administration for its Coronary Over-the-Wire Balloon Dilatation Catheter, Jingyi. The device is indicated for dilating coronary artery or coronary artery bypass vessel stenosis to improve myocardial perfusion, with certain configurations also approved for post-stent dilation. The company highlighted that Jingyi features a semi-compliant balloon and an optimized delivery system designed for improved crossability and pushability, making it suitable for complex lesions. Acotec plans to commence marketing activities for the product in the Chinese market at an appropriate time. The company cautioned that successful commercialization is not guaranteed. No other organizations were mentioned as recipients of this regulatory approval.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acotec Scientific Holdings Ltd. published the original content used to generate this news brief on November 18, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10